| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
98,550 |
76,575 |
$6.65M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,010 |
10,450 |
$645K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
3,234 |
3,182 |
$302K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
15,351 |
14,569 |
$196K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,786 |
1,762 |
$160K |
| 99385 |
|
1,593 |
1,566 |
$157K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,291 |
3,194 |
$133K |
| 99215 |
Prolong outpt/office vis |
1,993 |
1,638 |
$118K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,426 |
2,210 |
$110K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,218 |
1,211 |
$106K |
| 36415 |
Collection of venous blood by venipuncture |
32,925 |
31,066 |
$98K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,116 |
1,104 |
$97K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
960 |
933 |
$78K |
| 99386 |
|
629 |
617 |
$69K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
461 |
437 |
$59K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
607 |
605 |
$58K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,149 |
3,648 |
$53K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,166 |
2,102 |
$49K |
| 93000 |
|
3,158 |
3,065 |
$37K |
| 81002 |
|
12,783 |
11,277 |
$33K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,187 |
1,098 |
$30K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
795 |
776 |
$17K |
| 99397 |
|
517 |
504 |
$17K |
| 99205 |
Prolong outpt/office vis |
98 |
96 |
$12K |
| 82962 |
|
6,084 |
5,078 |
$12K |
| 99383 |
|
134 |
129 |
$12K |
| 99497 |
|
971 |
942 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
362 |
344 |
$10K |
| 93229 |
|
12 |
12 |
$10K |
| 90686 |
|
1,185 |
1,074 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
650 |
631 |
$9K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
31 |
31 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
81 |
75 |
$7K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
80 |
77 |
$6K |
| 99384 |
|
57 |
57 |
$6K |
| 90461 |
|
75 |
74 |
$6K |
| 99382 |
|
72 |
61 |
$5K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
655 |
621 |
$5K |
| 99457 |
|
136 |
132 |
$5K |
| J2785 |
Injection, regadenoson, 0.1 mg |
28 |
28 |
$5K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
28 |
28 |
$4K |
| 94760 |
|
2,097 |
1,732 |
$3K |
| 99454 |
|
91 |
91 |
$3K |
| 96160 |
|
1,604 |
1,540 |
$3K |
| 90682 |
|
97 |
89 |
$3K |
| 90688 |
|
217 |
205 |
$3K |
| 99381 |
|
27 |
27 |
$2K |
| 81025 |
|
344 |
318 |
$2K |
| 96127 |
|
495 |
495 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
56 |
56 |
$2K |
| 99173 |
|
1,915 |
1,795 |
$2K |
| 87428 |
|
31 |
30 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
29 |
28 |
$2K |
| 94664 |
|
93 |
88 |
$2K |
| 0011A |
|
46 |
46 |
$1K |
| 99188 |
|
107 |
105 |
$1K |
| 99458 |
|
44 |
41 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
744 |
696 |
$1K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
443 |
394 |
$1K |
| 90662 |
|
88 |
80 |
$1K |
| 90756 |
|
47 |
26 |
$975.72 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
31 |
24 |
$686.88 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
251 |
237 |
$670.06 |
| 0012A |
|
19 |
17 |
$522.00 |
| 93016 |
|
32 |
32 |
$486.71 |
| 99453 |
|
30 |
30 |
$425.51 |
| 99000 |
|
384 |
295 |
$393.85 |
| 93228 |
|
13 |
13 |
$286.13 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
205 |
191 |
$282.57 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
173 |
151 |
$282.20 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
48 |
45 |
$271.37 |
| 90651 |
|
141 |
132 |
$250.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
61 |
58 |
$228.33 |
| 82270 |
|
42 |
42 |
$171.97 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
128 |
92 |
$158.19 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
40 |
39 |
$147.18 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16 |
14 |
$117.40 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
16 |
16 |
$85.73 |
| 90656 |
|
38 |
27 |
$75.68 |
| 94761 |
|
15 |
14 |
$29.22 |
| G0008 |
Administration of influenza virus vaccine |
118 |
108 |
$22.42 |
| 1159F |
|
8,633 |
6,572 |
$19.68 |
| 99072 |
|
314 |
226 |
$16.80 |
| 3008F |
|
6,125 |
4,685 |
$7.98 |
| 2000F |
|
976 |
836 |
$7.98 |
| 99499 |
|
1,407 |
1,115 |
$2.84 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
5,119 |
3,326 |
$0.16 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,345 |
900 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
184 |
136 |
$0.00 |
| 3077F |
|
682 |
552 |
$0.00 |
| 3078F |
|
2,882 |
2,341 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
1,883 |
1,278 |
$0.00 |
| 4040F |
|
149 |
128 |
$0.00 |
| 4013F |
|
2,797 |
2,125 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
272 |
182 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,532 |
1,034 |
$0.00 |
| 1160F |
|
639 |
515 |
$0.00 |
| 3050F |
|
96 |
91 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
213 |
121 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
372 |
265 |
$0.00 |
| 90633 |
|
157 |
153 |
$0.00 |
| 3288F |
|
211 |
181 |
$0.00 |
| 90670 |
|
322 |
307 |
$0.00 |
| 1100F |
|
40 |
33 |
$0.00 |
| 1090F |
|
44 |
37 |
$0.00 |
| 3095F |
|
164 |
141 |
$0.00 |
| 0518F |
|
17 |
14 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
13 |
13 |
$0.00 |
| 3725F |
|
15 |
12 |
$0.00 |
| 3074F |
|
2,017 |
1,651 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
2,527 |
1,670 |
$0.00 |
| 3075F |
|
376 |
339 |
$0.00 |
| G8542 |
Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required |
294 |
244 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
991 |
632 |
$0.00 |
| 4086F |
|
778 |
573 |
$0.00 |
| 3017F |
|
200 |
168 |
$0.00 |
| 3048F |
|
592 |
544 |
$0.00 |
| 1125F |
|
48 |
43 |
$0.00 |
| 3079F |
|
718 |
645 |
$0.00 |
| 1036F |
|
1,080 |
988 |
$0.00 |
| 4010F |
|
2,612 |
1,915 |
$0.00 |
| 3080F |
|
90 |
79 |
$0.00 |
| 3044F |
|
934 |
824 |
$0.00 |
| 1126F |
|
143 |
122 |
$0.00 |
| 4008F |
|
682 |
502 |
$0.00 |
| G8734 |
Elder maltreatment screen documented as negative, follow-up is not required |
226 |
196 |
$0.00 |
| 4210F |
|
368 |
264 |
$0.00 |
| 0001F |
|
127 |
108 |
$0.00 |
| 3014F |
|
45 |
39 |
$0.00 |
| 90696 |
|
15 |
13 |
$0.00 |
| 90677 |
|
86 |
84 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
179 |
156 |
$0.00 |
| 3049F |
|
133 |
131 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
217 |
188 |
$0.00 |
| 90620 |
|
29 |
29 |
$0.00 |
| 1170F |
|
277 |
236 |
$0.00 |
| 1220F |
|
15 |
12 |
$0.00 |
| 99070 |
|
280 |
199 |
$0.00 |
| 90619 |
|
12 |
12 |
$0.00 |
| 1111F |
|
87 |
48 |
$0.00 |
| 1101F |
|
170 |
150 |
$0.00 |
| 90680 |
|
128 |
124 |
$0.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
17 |
15 |
$0.00 |
| 2001F |
|
18 |
18 |
$0.00 |
| 1123F |
|
26 |
26 |
$0.00 |
| 90697 |
|
27 |
25 |
$0.00 |
| 2010F |
|
23 |
23 |
$0.00 |